Zhihui Lang

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 320 citations

Medicine, Cardiology, Pharmacology +16

Phase I Evaluation of a Fully Human Anti–αv Integrin Monoclonal Antibody (CNTO 95) in Patients with Advanced Solid Tumors

Saifee Mullamitha, N.C. Ton, Geoff J.M. Parker et al. · Clinical Cancer Research · 2007 · 142 citations

Medicine, Oncology, Pharmacology +17

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma

Steven O’Day, Anna C. Pavlick, Carmen Loquai et al. · British Journal of Cancer · 2011 · 118 citations · Full text

Medicine, Oncology, Pharmacology +16

Ganglioside GD1a Enhances VEGF-Induced Endothelial Cell Proliferation and Migration

Zhihui Lang, Michael F. Guerrera, R Li et al. · Biochemical and Biophysical Research Communications · 2001 · 63 citations

Life Sciences, Cell Biology, Oncology +10

Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma <i>in situ</i> of the bladder

Michael S. Cookson, Sam S. Chang, Christine Lihou et al. · Therapeutic Advances in Urology · 2014 · 50 citations · Full text

Medicine, Oncology, Urology +11